Company Performance Metrics
- Anne Wojcicki: Founder and CEOPast Role: Passport Capital, Healthcare Analyst
Richard Scheller: Chief Science Officer and Head of TherapeuticsPast Role: Genentech, Senior Vice President of Research
23andMe is a leading genetics-led health company dedicated to helping individuals understand the human genome. Through its consumer platform, the company provides actionable insights into ancestry, inherited traits, and genetic health risks, empowering people to take a proactive and preventative approach to their long-term wellness. By making
genetic information accessible and understandable, 23andMe helps users discover their heritage while identifying potential health predispositions.
Beyond its consumer services, the organization operates the 23andMe Research Institute, a mission-driven initiative that collaborates with the global scientific community to accelerate medical breakthroughs. With one of the world's largest databases of consented genetic and phenotypic information, the company is at the forefront of therapeutic discovery and precision medicine. 23andMe remains committed to its goal of leveraging genetic data to improve human health, drive scientific innovation, and provide researchers with the tools needed to combat complex diseases.